Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 13 Recruiting 8 Completed 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Specimen Handling 8 Nivolumab 6 pembrolizumab 4 lenvatinib 3 Ipilimumab 3 Biopsy 3 Axitinib 3 vorolanib 2 fludarabine 2 cabozantinib 2 anlotinib 2 Sunitinib 2 Nephrectomy 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CTLA-4 Antigen 2 toripalimab 1 tivozanib 1 sodium-iodide symporter 1 sintilimab 1 pazopanib 1 fludarabine phosphate 1 cemiplimab 1 bemarituzumab 1 belzutifan 1 balstilimab 1 Zoledronic Acid 1 Saline Solution 1 Rubidium-82 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Renal Cell × belzutifan × Clear all

NCT07593040 2026-05-20

Moonlanding

Vall d'Hebron Institute of Oncology

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡